⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
High antipsychotic prescribing (65+)Extreme fills per patient
Risk indicators are statistical patterns, not allegations. Learn more
9,429
Total Claims
$889K
Drug Cost
268
Beneficiaries
$3,318
Cost/Patient
Risk Score Breakdown 17/100
Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
High fills per patient+5
Score components are additive. Read full methodology
Peer Comparison vs. 6,382 Endocrinology providers
-16%
Cost per patient vs peers
$3,318 vs $3,933 avg
-78%
Brand preference vs peers
11.3% vs 51.2% avg
Brand vs Generic
89% generic
Brand: 1,032 claims · $613K
Generic: 8,078 claims · $262K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 55 | $81K |
| Emtricitab/Rilpiviri/Tenof Ala | 12 | $44K |
| Chlorpromazine Hcl | 72 | $43K |
| Dulaglutide | 38 | $42K |
| Insulin Aspart | 48 | $32K |
| Empagliflozin | 41 | $31K |
| Insulin Detemir | 52 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 47 | $26K |
| Apixaban | 27 | $20K |
| Dextromethorphan Hbr/Quinidine | 12 | $20K |
| Insulin Lispro | 19 | $17K |
| Mirabegron | 28 | $14K |
| Dapagliflozin Propanediol | 17 | $13K |
| Insulin Degludec | 18 | $12K |
| Rivaroxaban | 17 | $9,944 |
Prescribing Profile
Patient Profile
66
Avg Age
47%
Female
1.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About